By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics developer AltheaDx said today that it has reeled in $6 million in a Series A round of equity financing led by Telegraph Hill Partners of San Francisco.

AltheaDx will use the funds to support its partnerships with biopharmaceutical firms focused on developing companion diagnostics and biomarkers for use in making therapeutics safer, AltheaDx Co-founder and Co-CEO Magda Marquet said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.